Use of CGM in Kidney Transplant Recipients
Continuous Glucose Monitoring (CGM) to Improve Glycemic Control in Kidney Transplant Recipients
University of California, Davis
80 participants
Jun 29, 2021
INTERVENTIONAL
Conditions
Summary
The investigators want to study the impact CGM (continuous glucose monitoring) has on patients glycemic control as determined by time in range (TIR 70-180 mg/dL) in the Diabetic Kidney Transplant population.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
access to continuous glucose monitoring in the Dexcom G6 arm 24/7
retrospective access to continuous glucose profile after 10 days of wear
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04783441